Stock Events

Stock Events

Kalaris Therapeutics (KLRS) Q3 2026 Earnings

11AugConfirmed

Q3 2025

Q4 2025

Q2 2026

Q3 2026

-0.64

-0.58

-0.52

-0.46

Details

Expected EPS

-0.495

Actual EPS

-0.48

Surprise EPS

0.02

Surprise Percent

+3.03%

Description

Kalaris Therapeutics (KLRS) has reported earnings of -0.48 per share for Q3 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.